Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

TCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeys.

Osuna CE, Gonzalez AM, Chang HH, Hung AS, Ehlinger E, Anasti K, Alam SM, Letvin NL.

PLoS Pathog. 2014 Apr 17;10(4):e1004069. doi: 10.1371/journal.ppat.1004069. eCollection 2014 Apr.

PMID:
24743648
[PubMed - in process]
Free PMC Article
2.

Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.

Testa JS, Philip R.

Future Virol. 2012 Nov 1;7(11):1077-1088.

PMID:
23630544
[PubMed]
Free PMC Article
3.

HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.

Kulkarni V, Rosati M, Valentin A, Ganneru B, Singh AK, Yan J, Rolland M, Alicea C, Beach RK, Zhang GM, Le Gall S, Broderick KE, Sardesai NY, Heckerman D, Mothe B, Brander C, Weiner DB, Mullins JI, Pavlakis GN, Felber BK.

PLoS One. 2013;8(3):e60245. doi: 10.1371/journal.pone.0060245. Epub 2013 Mar 28.

PMID:
23555935
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Liu MK, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M, Treurnicht F, Hraber P, Riou C, Gray C, Ferrari G, Tanner R, Ping LH, Anderson JA, Swanstrom R; CHAVI Core B, Cohen M, Karim SS, Haynes B, Borrow P, Perelson AS, Shaw GM, Hahn BH, Williamson C, Korber BT, Gao F, Self S, McMichael A, Goonetilleke N.

J Clin Invest. 2013 Jan 2;123(1):380-93. doi: 10.1172/JCI65330. Epub 2012 Dec 10.

PMID:
23221345
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.

Champiat S, Raposo RA, Maness NJ, Lehman JL, Purtell SE, Hasenkrug AM, Miller JC, Dean H, Koff WC, Hong MA, Martin JN, Deeks SG, Spotts GE, Pilcher CD, Hecht FM, Kallas EG, Garrison KE, Nixon DF.

PLoS One. 2012;7(6):e39311. doi: 10.1371/journal.pone.0039311. Epub 2012 Jun 29.

PMID:
22768072
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.

Eller MA, Slike BM, Cox JH, Lesho E, Wang Z, Currier JR, Darden JM, Polonis VR, Vahey MT, Peel S, Robb ML, Michael NL, Marovich MA.

PLoS One. 2011;6(9):e24254. doi: 10.1371/journal.pone.0024254. Epub 2011 Sep 16.

PMID:
21949699
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity.

Battivelli E, Migraine J, Lecossier D, Yeni P, Clavel F, Hance AJ.

J Virol. 2011 Nov;85(22):11846-54. doi: 10.1128/JVI.05201-11. Epub 2011 Sep 14.

PMID:
21917976
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection.

Radebe M, Nair K, Chonco F, Bishop K, Wright JK, van der Stok M, Bassett IV, Mncube Z, Altfeld M, Walker BD, Ndung'u T.

J Infect Dis. 2011 Sep 1;204(5):768-76. doi: 10.1093/infdis/jir394.

PMID:
21844303
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolates.

Agwale SM, Forbi JC, Notka F, Wrin T, Wild J, Wagner R, Wolf H.

PLoS One. 2011;6(8):e23233. doi: 10.1371/journal.pone.0023233. Epub 2011 Aug 4.

PMID:
21829720
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.

PLoS One. 2011;6(7):e21135. doi: 10.1371/journal.pone.0021135. Epub 2011 Jul 19.

PMID:
21818255
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

High-avidity, high-IFN╬│-producing CD8 T-cell responses following immune selection during HIV-1 infection.

Keane NM, Roberts SG, Almeida CA, Krishnan T, Chopra A, Demaine E, Laird R, Tschochner M, Carlson JM, Mallal S, Heckerman D, James I, John M.

Immunol Cell Biol. 2012 Feb;90(2):224-34. doi: 10.1038/icb.2011.34. Epub 2011 May 17.

PMID:
21577229
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.

Lazaro E, Kadie C, Stamegna P, Zhang SC, Gourdain P, Lai NY, Zhang M, Martinez SA, Heckerman D, Le Gall S.

J Clin Invest. 2011 Jun;121(6):2480-92. doi: 10.1172/JCI44932. Epub 2011 May 9.

PMID:
21555856
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.

Ritchie AJ, Campion SL, Kopycinski J, Moodie Z, Wang ZM, Pandya K, Moore S, Liu MK, Brackenridge S, Kuldanek K, Legg K, Cohen MS, Delwart EL, Haynes BF, Fidler S, McMichael AJ, Goonetilleke N.

J Virol. 2011 Apr;85(7):3507-16. doi: 10.1128/JVI.02444-10. Epub 2011 Jan 26.

PMID:
21270166
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

Keckler MS, Hodara VL, Parodi LM, Giavedoni LD.

J Biomed Biotechnol. 2010;2010:279391. doi: 10.1155/2010/279391. Epub 2010 May 25.

PMID:
20589067
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.

Schweighardt B, Wrin T, Meiklejohn DA, Spotts G, Petropoulos CJ, Nixon DF, Hecht FM.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):36-46. doi: 10.1097/QAI.0b013e3181c4b885.

PMID:
19910798
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.

Liu Y, McNevin J, Rolland M, Zhao H, Deng W, Maenza J, Stevens CE, Collier AC, McElrath MJ, Mullins JI.

J Infect Dis. 2009 Dec 15;200(12):1825-33. doi: 10.1086/648401.

PMID:
19909083
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo.

Wick WD, Gilbert PB, Yang OO.

J Virol. 2009 Mar;83(5):2349-56. doi: 10.1128/JVI.00821-08. Epub 2008 Dec 17.

PMID:
19091857
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1.

Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, Goodman R, Schneidewind A, Power KA, Toth I, Frahm N, Alter G, Brander C, Carrington M, Walker BD, Altfeld M, Heckerman D, Allen TM.

J Virol. 2009 Feb;83(4):1845-55. doi: 10.1128/JVI.01061-08. Epub 2008 Nov 26.

PMID:
19036810
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level.

Erickson AL, Willberg CB, McMahan V, Liu A, Buchbinder SP, Grohskopf LA, Grant RM, Nixon DF.

Clin Vaccine Immunol. 2008 Nov;15(11):1745-8. doi: 10.1128/CVI.00247-08. Epub 2008 Sep 24.

PMID:
18815234
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Optimizing peptide matrices for identifying T-cell antigens.

Precopio ML, Butterfield TR, Casazza JP, Little SJ, Richman DD, Koup RA, Roederer M.

Cytometry A. 2008 Nov;73(11):1071-8. doi: 10.1002/cyto.a.20646.

PMID:
18781655
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk